Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-25-002101

Chief Operating Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Champoux Jennifer Chief Operating Officer 2025-01-02 Grant or award +30,000 30,000 D
Derivatives
Champoux Jennifer Chief Operating Officer 2025-01-02 Grant or award · Stock Option (Right to Buy) +135,000 135,000 D
Loading xslF345X05/ownership.xml…